Intellia Therapeutics, Inc.

NTLA - Company ID 0001652130

Market cap$2.03 B

Rank#2118

Filings679

Intellia Therapeutics, Inc. has filed 679 public company documents between 2015 and 2026. The most frequent type is insider trade (284 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.

Continue researchNTLA overview$2.03 BMarket cap, financials, charts, and latest company context.

Continue researchMarket cap historyRank #2118See the market value trend behind the filing history.

Continue researchRevenue trendAnnual historyMove from documents into filing-backed operating results.

Continue researchCompare with IDXXPeer viewPut NTLA beside IDXX across market cap, revenue, income, and filings.

Browse latest filings across all companies →Follow NTLA via RSS

Similar companies to research next

IDXXIDEXX Laboratories, Inc.LLNTHLantheus Holdings, Inc.

CLDXCelldex Therapeutics, Inc.

NEOGNeogen Corporation NNNNNAnbio Biotechnology

Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.

Type	Filing	Filed	Period covered	Open
SCHEDULE 13G/A	SCHEDULE 13G/A	3mo ago2026-03-27	-	View filing
SCHEDULE 13G/A	SCHEDULE 13G/A	4mo ago2026-02-11	-	View filing
SCHEDULE 13G/A	SCHEDULE 13G/A	5mo ago2026-02-03	-	View filing
SCHEDULE 13G/A	SCHEDULE 13G/A	5mo ago2026-01-30	-	View filing
SCHEDULE 13G/A	SCHEDULE 13G/A	8mo ago2025-11-04	-	View filing
SCHEDULE 13G/A	SCHEDULE 13G/A	1y ago2025-04-17	-	View filing
SCHEDULE 13G/A	SCHEDULE 13G/A	1y ago2025-01-08	-	View filing

Intellia Therapeutics, Inc.

Similar companies to research next

Year